By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aerie Pharmaceuticals, Inc. (AERI) Added To NASDAQ Biotechnology Index (NBI) 12/16/2014 10:41:47 AM
Aerie Pharmaceuticals, Inc. (AERI) Completes Enrollment In Phase 3 Registration Trial ("Rocket 1") Of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma 12/2/2014 8:56:23 AM
Aerie Pharmaceuticals, Inc. (AERI) To Present At Piper Jaffray 26th Annual Healthcare Conference 11/24/2014 10:42:07 AM
Aerie Pharmaceuticals, Inc. (AERI) Reports Third Quarter 2014 Financial Results And Provides Business And Product Development Update 11/12/2014 2:33:08 PM
Aerie Pharmaceuticals, Inc. (AERI) To Present At The 2014 Stifel Nicolaus Annual Healthcare Conference 11/12/2014 10:01:42 AM
Aerie Pharmaceuticals, Inc. (AERI) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 11, 2014 10/28/2014 9:54:57 AM
Aerie Pharmaceuticals, Inc. (AERI) Elects Benjamin F. Mcgraw, III To Its Board Of Directors 10/7/2014 10:55:05 AM
Aerie Pharmaceuticals, Inc. (AERI) Announces Closing Of $125 Million Convertible Notes Financing 10/1/2014 9:34:49 AM
New Jersey's Aerie Pharmaceuticals, Inc. (AERI) Grabs $125 Million Financing Commitment 9/9/2014 6:08:03 AM
Aerie Pharmaceuticals, Inc. (AERI) Initiates Phase 3 Safety-Only Registration Trial in Canada Of Rhopressa™ In Patients With Glaucoma 9/3/2014 12:34:31 PM
12345
//-->